Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.05 is 149% above its 1-year average of -0.10, near the high end of its 1-year range (-0.29–0.05).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.05.
DEBT TO EQUITY RATIO
0.05
DEBT TO EQUITY RATIO AVG TTM
N/A
DEBT TO EQUITY RATIO AVG 3Y
N/A
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 717 covered companies
CURRENT VS SECTOR MEDIAN
-55.62%
vs the sector median at left
Mobia Medical, Inc. Common Stock
Market Cap
$302.22M
Debt to Equity Ratio
0.05
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$300.58M
Debt to Equity Ratio
0.00
TTM Avg
0.01
3Y Avg
0.70
5Y Avg
0.51
Market Cap
$313.14M
Debt to Equity Ratio
0.23
TTM Avg
0.27
3Y Avg
0.28
5Y Avg
0.22
Market Cap
$292.16M
Debt to Equity Ratio
0.04
TTM Avg
0.04
3Y Avg
0.05
5Y Avg
0.06
Market Cap
$290.94M
Debt to Equity Ratio
0.05
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.50
Market Cap
$287.05M
Debt to Equity Ratio
0.01
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$285.61M
Debt to Equity Ratio
0.16
TTM Avg
0.34
3Y Avg
0.33
5Y Avg
0.27
Market Cap
$285.37M
Debt to Equity Ratio
0.00
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
0.01
Market Cap
$321.48M
Debt to Equity Ratio
6.11
TTM Avg
4.48
3Y Avg
2.31
5Y Avg
1.55
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobia Medical, Inc. Common Stock (MOBI) | $302.22M | 0.05 | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $300.58M | 0.00 | 0.01 | 0.70 | 0.51 |
| C4 Therapeutics, Inc. (CCCC)vs › | $313.14M | 0.23 | 0.27 | 0.28 | 0.22 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $292.16M | 0.04 | 0.04 | 0.05 | 0.06 |
| Standard BioTools Inc. (LAB)vs › | $290.94M | 0.05 | 0.07 | 0.07 | 0.50 |
| Sagimet Biosciences Inc. (SGMT)vs › | $287.05M | 0.01 | 0.00 | 0.00 | 0.00 |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.61M | 0.16 | 0.34 | 0.33 | 0.27 |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.37M | 0.00 | 0.01 | 0.01 | 0.01 |
| Sanara MedTech Inc. (SMTI)vs › | $321.48M | 6.11 | 4.48 | 2.31 | 1.55 |
| Avita Medical Inc. (RCEL)vs › | $321.44M | N/A | 5.54 | 2.78 | 1.86 |
Debt/Equity
0.05
Current Ratio
13.28
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.05 |
| 2026-03-31 | -0.29 |
| 2025-12-31 | -0.06 |
